JWK010 gene therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JWK010 gene therapy, covering 2026-01-12 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of a Single Suprachoroidal Injection of JWK010 Gene Therapy in Subjects With Oculocutaneous Albinism Type 1 (OCA1) [EARLY_Phase 1]